A study evaluating 68Ga-PSMA ligand positron-emission tomography–computed tomography (PET/CT)-based radiotherapy for lymph node metastases of prostate cancer after primary therapy.
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Oct 2017 New trial record